APA
Ledermann J. A., Oza A. M., Lorusso D., Aghajanian C., Oaknin A., Dean A., Colombo N., Weberpals J. I., Clamp A. R., Scambia G., Leary A., Holloway R. W., Gancedo M. A., Fong P. C., Goh J. C., O'Malley D. M., Armstrong D. K., Banerjee S., García-Donas J., Swisher E. M., Cameron T., Maloney L., Goble S. & Coleman R. L. (20200709). Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. : The Lancet. Oncology.
Chicago
Ledermann Jonathan A, Oza Amit M, Lorusso Domenica, Aghajanian Carol, Oaknin Ana, Dean Andrew, Colombo Nicoletta, Weberpals Johanne I, Clamp Andrew R, Scambia Giovanni, Leary Alexandra, Holloway Robert W, Gancedo Margarita Amenedo, Fong Peter C, Goh Jeffrey C, O'Malley David M, Armstrong Deborah K, Banerjee Susana, García-Donas Jesus, Swisher Elizabeth M, Cameron Terri, Maloney Lara, Goble Sandra and Coleman Robert L. 20200709. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. : The Lancet. Oncology.
Harvard
Ledermann J. A., Oza A. M., Lorusso D., Aghajanian C., Oaknin A., Dean A., Colombo N., Weberpals J. I., Clamp A. R., Scambia G., Leary A., Holloway R. W., Gancedo M. A., Fong P. C., Goh J. C., O'Malley D. M., Armstrong D. K., Banerjee S., García-Donas J., Swisher E. M., Cameron T., Maloney L., Goble S. and Coleman R. L. (20200709). Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. : The Lancet. Oncology.
MLA
Ledermann Jonathan A, Oza Amit M, Lorusso Domenica, Aghajanian Carol, Oaknin Ana, Dean Andrew, Colombo Nicoletta, Weberpals Johanne I, Clamp Andrew R, Scambia Giovanni, Leary Alexandra, Holloway Robert W, Gancedo Margarita Amenedo, Fong Peter C, Goh Jeffrey C, O'Malley David M, Armstrong Deborah K, Banerjee Susana, García-Donas Jesus, Swisher Elizabeth M, Cameron Terri, Maloney Lara, Goble Sandra and Coleman Robert L. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. : The Lancet. Oncology. 20200709.